ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2025-50106

Vulnerability in the Oracle Java SE, Oracle GraalVM for JDK, Oracle GraalVM Enterprise Edition product of Oracle Java SE (component: 2D).

Published Jul 15, 2025 · catalog updated Feb 26, 2026 · Oracle Corporation Oracle Java SE

Check this week

CVE-2025-50106 is not in CISA KEV. FIRST estimates a 75.00% chance of exploitation in the next 30 days. Check whether you run Oracle Corporation Oracle Java SE.

Gaps on this record

  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
High8.1
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
75.00%
Remediation
Advisory link
Affected products
vendor Oracle Corporation Oracle Java SE 21.0.7

Vulnerability in the Oracle Java SE, Oracle GraalVM for JDK, Oracle GraalVM Enterprise Edition product of Oracle Java SE (component: 2D). Supported versions that are affected are Oracle Java SE: 8u451, 8u451-perf, 11.0.27, 17.0.15, 21.0.7, 24.0.1; Oracle GraalVM for JDK: 17.0.15, 21.0.7 and 24.0.1; Oracle GraalVM Enterprise Edition: 21.3.14. Difficult to exploit vulnerability allows unauthenticated attacker with network access via multiple protocols to compromise Oracle Java SE, Oracle GraalVM for JDK, Oracle GraalVM Enterprise Edition. Successful attacks of this vulnerability can result in ta

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • vendor Oracle Corporation Oracle Java SE 21.0.721.0.7

How to fix CVE-2025-50106

  • Recommended remediation

    A patch or advisory reference is linked. Open the original publisher for availability by product version.

  • Official advisories

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

CVE-2025-50106 is not in CISA KEV. FIRST estimates a 75.00% chance of exploitation in the next 30 days. Check whether you run Oracle Corporation Oracle Java SE.

Which versions are affected?

Compare what you have installed with Oracle Corporation Oracle Java SE 21.0.7 21.0.7. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

No weakness class is stored. EPSS 75.00%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Jul 15, 2025 · EUVD

    Detected

    Vulnerability in the Oracle Java SE, Oracle GraalVM for JDK, Oracle GraalVM Enterprise Edition product of Oracle Java SE (component: 2D). Supported versions that are affected are Oracle Java SE: 8u451, 8u451-perf, 11.0.27, 17.0.15, 21.0.7, 24.0.1; Oracle GraalVM for JDK: 17.0.15, 21.0.7 and 24.0.1; Oracle GraalVM Enterprise Edition: 21.3.14. Difficult to exploit vulnerability allows unauthenticate

  2. Feb 26, 2026 · EUVD

    Updated

    Vulnerability in the Oracle Java SE, Oracle GraalVM for JDK, Oracle GraalVM Enterprise Edition product of Oracle Java SE (component: 2D). Supported versions that are affected are Oracle Java SE: 8u451, 8u451-perf, 11.0.27, 17.0.15, 21.0.7, 24.0.1; Oracle GraalVM for JDK: 17.0.15, 21.0.7 and 24.0.1; Oracle GraalVM Enterprise Edition: 21.3.14. Difficult to exploit vulnerability allows unauthenticate

Sources

  • EUVDVulnerability recordEUVD-2025-21474

    Vulnerability in the Oracle Java SE, Oracle GraalVM for JDK, Oracle GraalVM Enterprise Edition product of Oracle Java SE (component: 2D). Supported versions that are affected are Oracle Java SE: 8u451, 8u451-perf, 11.0.27, 17.0.15, 21.0.7, 24.0.1; Oracle GraalVM for JDK: 17.0.15,

    euvd.enisa.europa.eu

References

Freshness

Last verified in this catalog Feb 26, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.